NCT07165795
Pilot Study to Evaluate the Effect of Transcendental Meditation on Telomere Activity and Well-Being Among Nurse Managers
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
Notable Eligibility criteria expanded, about 3 words Show 4 more changesShow less
- Trial status changed: Enrolling by Invitation → Completed
- Primary completion date changed from estimate of May 2027 to Nov 13, 2025
- Enrollment target: estimated 30 to confirmed 31
- Secondary endpoints: details revised at 5 of 5 entries
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Telomere Length
Timeframe: baseline, 1-month, 4-months
Telomerase Activity
Timeframe: baseline, 1-month, 4-months
Secondary (5)
Work-Life Climate Scale
Secure Flourishing Index, SFI
Perceived Stress Scale-10 (PSS10)
Maslach Burnout Inventory Human Services Survey for Medical Personnel
Power as Knowing Participation in Change (PKPCT)
Arms and interventions
Immediate TM InstructionExperimental
This group will receive initial TM instruction within three weeks of baseline assessments with follow-up interventions every 2-4 weeks and an expectation of home practice of two 20min meditation sessions per day.
Control Group (delayed instruction)No intervention
This group will be eligible to receive TM instruction upon completion of the final 4-month assessments, and asked to continue with routine activities throughout study.
Behavioral: Transcendental Meditation
Sites
1 site in 1 country
- Sarasota Memorial Health Care SystemSarasota, Florida, United States